Sponsor pipeline

MBX Biosciences clinical trial pipeline

Get alerts when MBX Biosciences's trials change

3 active trials 2 recruiting 1 Phase 3 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-08

What changed in the last 30 days

2026-10-08
Notable
NCT06531941 Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients… · Phase 2

Active trials by phase

Phase 1
1
Phase 2
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07699471 A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With… Hypoparathyroidism Recruiting 2026-09-24
Phase 2
NCT06531941 Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients… Hypoparathyroidism Active, Not Recruiting 2026-10-07
Phase 1
NCT07142707 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… Obesity Recruiting 2026-06-09

Disease areas by active trials

Get alerts when MBX Biosciences's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free